| |
| |
| |
| General principles | |
| |
| |
| |
| What is pharmacology? | |
| |
| |
| |
| How drugs act: general principles | |
| |
| |
| |
| How drugs act: molecular aspects | |
| |
| |
| |
| How drugs act: cellular aspects-excitation, contraction and secretion | |
| |
| |
| |
| Cell proliferation, apoptosis, repair and regeneration | |
| |
| |
| |
| Cellular mechanisms: host defence | |
| |
| |
| |
| Method and measurement in pharmacology | |
| |
| |
| |
| Drug absorption and distribution | |
| |
| |
| |
| Drug metabolism and elimination | |
| |
| |
| |
| Pharmacokinetics | |
| |
| |
| |
| Pharmacogenetics, pharmacogenomics and 'personalised medicine' | |
| |
| |
| |
| Chemical mediators | |
| |
| |
| |
| Chemical mediators and the autonomic nervous system | |
| |
| |
| |
| Cholinergic transmission | |
| |
| |
| |
| Noradrenergic transmission | |
| |
| |
| |
| 5-Hydroxytryptamine and the pharmacology of migraine | |
| |
| |
| |
| Purines | |
| |
| |
| |
| Local hormones: cytokines, biologically active lipids, amines and�peptides | |
| |
| |
| |
| Cannabinoids | |
| |
| |
| |
| Peptides and proteins as mediators | |
| |
| |
| |
| Nitric oxide | |
| |
| |
| |
| Drugs affecting major organ systems | |
| |
| |
| |
| The heart | |
| |
| |
| |
| The vascular system | |
| |
| |
| |
| Atherosclerosis and lipoprotein metabolism | |
| |
| |
| |
| Haemostasis and thrombosis | |
| |
| |
| |
| Haemopoietic system and treatment of anaemia | |
| |
| |
| |
| Anti-inflammatory and immunosuppressant drugs | |
| |
| |
| |
| The respiratory system | |
| |
| |
| |
| The kidney | |
| |
| |
| |
| The gastrointestinal tract | |
| |
| |
| |
| The control of blood glucose and drug treatment of diabetes mellitus | |
| |
| |
| |
| Obesity | |
| |
| |
| |
| The pituitary and the adrenal cortex | |
| |
| |
| |
| The thyroid | |
| |
| |
| |
| The reproductive system | |
| |
| |
| |
| Bone metabolism | |
| |
| |
| |
| The nervous system | |
| |
| |
| |
| Chemical transmission and drug action in the central nervous system | |
| |
| |
| |
| Amino acid transmitters | |
| |
| |
| |
| Other transmitters and modulators | |
| |
| |
| |
| Neurodegenerative diseases | |
| |
| |
| |
| General anaesthetic agents | |
| |
| |
| |
| Analgesic drugs | |
| |
| |
| |
| Local anaesthetics and other drugs affecting sodium channels | |
| |
| |
| |
| Anxiolytic and hypnotic drugs | |
| |
| |
| |
| Antiepileptic drugs | |
| |
| |
| |
| Antipsychotic drugs | |
| |
| |
| |
| Antidepressant drugs | |
| |
| |
| |
| CNS stimulants and psychotomimetic drugs | |
| |
| |
| |
| Drug addiction, dependence and abuse | |
| |
| |
| |
| Drugs used for the treatment of infections, cancer and immunological disorders | |
| |
| |
| |
| Basic principles of antimicrobial chemotherapy | |
| |
| |
| |
| Antibacterial drugs | |
| |
| |
| |
| Antiviral drugs | |
| |
| |
| |
| Antifungal drugs | |
| |
| |
| |
| Antiprotozoal drugs | |
| |
| |
| |
| Anthelminthic drugs | |
| |
| |
| |
| Anticancer drugs | |
| |
| |
| |
| Special topics | |
| |
| |
| |
| Individual variation and drug interaction | |
| |
| |
| |
| Harmful effects of drugs | |
| |
| |
| |
| Lifestyle drugs and drugs in sport | |
| |
| |
| |
| Biopharmaceuticals and gene therapy | |
| |
| |
| |
| Drug discovery and development | |